Form 4: OnKure Therapeutics CEO Sells Shares
Insider Transaction (Form 4)
Nicholas A Saccomano, President and CEO and a Director of OnKure Therapeutics, Inc., sold 87 shares of common stock on September 21, 2026 for $2.97 per share.
Summary
- Open-market sale: disposed of 87 Class A Common Stock at $2.97 ($259) on September 21, 2026; holds 11,160 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $259 of stock on the open market.
Insider Transactions
Nicholas A Saccomano — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-21 | Open-market sale | Class A Common Stock | 87 | $3 | $259 | 11,160 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-21 | Open-market sale (87 shares) |
Keywords
insider transaction, Form 4, OKUR, OnKure Therapeutics, Inc., bearish, Nicholas A Saccomano
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.